Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification
- 30 November 2004
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 6 (4) , 356-365
- https://doi.org/10.1016/s1525-1578(10)60532-6
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono‐ and bi‐allelic 9p21 deletions in childhood acute lymphoblastic leukemiaGenes, Chromosomes and Cancer, 2003
- Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladderThe Journal of Pathology, 2002
- Quantitative real-time PCR does not show selective targeting of p14ARF but concomitant inactivation of both p16INK4A and p14ARF in 105 human primary gliomasOncogene, 2001
- Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31Oncogene, 1999
- Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumorsMolecular Carcinogenesis, 1995
- Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.Genome Research, 1995
- P16 gene in uncultured tumoursNature, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification ReactionsNature Biotechnology, 1993
- Simultaneous Amplification and Detection of Specific DNA SequencesBio/Technology, 1992